Atossa Therapeutics, Inc.
ATOSBiotechnology
$2.23−5.91%As of Oct 29vs prior close
- Market cap
- $22.3M
- P/E (TTM)
- –
- From 52W high
- −83.48%
- EPS (LTM)
- -$4.34
- Dividend yield
- 0.00%
Nomior Score
18
Steady ProfileBottom 6% of the scored universe
Growth—
Quality33
Value35
Momentum9
Resilience34
Connections
Who owns it
1fund